-
Signature
-
/s/ Brian Sandstrom, as Attorney-in-Fact
-
Stock symbol
-
MRNA
-
Transactions as of
-
Oct 29, 2021
-
Transactions value $
-
-$3,275,350
-
Form type
-
4
-
Date filed
-
11/2/2021, 04:16 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
MRNA |
Common Stock |
Options Exercise |
$61.1K |
+5K |
|
$12.21* |
5K |
Oct 29, 2021 |
Direct |
F1 |
transaction |
MRNA |
Common Stock |
Sale |
-$1.72M |
-5K |
-100% |
$344.49 |
0 |
Oct 29, 2021 |
Direct |
F1 |
transaction |
MRNA |
Common Stock |
Options Exercise |
$61.1K |
+5K |
|
$12.21* |
5K |
Nov 1, 2021 |
Direct |
F1 |
transaction |
MRNA |
Common Stock |
Sale |
-$1.68M |
-5K |
-100% |
$335.00 |
0 |
Nov 1, 2021 |
Direct |
F1 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
MRNA |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-5K |
-3.57% |
$0.00 |
135K |
Oct 29, 2021 |
Common Stock |
5K |
$12.21 |
Direct |
F1, F2 |
transaction |
MRNA |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-5K |
-3.7% |
$0.00 |
130K |
Nov 1, 2021 |
Common Stock |
5K |
$12.21 |
Direct |
F1, F2 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
Remarks:
Chief Technical Operations and Quality Officer